Heron Therapeutics (HRTX) FCF/share US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| FCF/share, rub | -2.10 | -1.36 | -0.44 | -0.16 | -0.17 | -0.11 | |||
| Changes by years, y/y, % | -1% | -35% | -68% | -64% | +5% | -39.8% | |||
Heron Therapeutics. FCF/share, rub
Heron Therapeutics. FCF/share, changes, %
Heron Therapeutics (HRTX) FCF/share US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| FCF/share, rub | -0.06 | -0.07 | 0.01 | -0.06 | -0.01 | -0.11 | ||
| Changes by years, y/y, % | -7% | +109% | -59% | -32% | -83% | |||
| Changes by quarters, q/q, % | -28% | +23% | -111% | -805% | -82% | |||